LOGIN  |  REGISTER
C4 Therapeutics

UnitedHealth Updates on Annual Shareholder Meeting, Board Actions

June 04, 2025 | Last Trade: US$307.70 3.99 1.31

Jun 04, 2025 / Business Wire / UnitedHealth Group (NYSE: UNH) provided updates on its 2025 annual shareholder meeting and actions taken by its Board of Directors.

Shareholders re-elected all current directors: Charles Baker, Timothy Flynn, Paul Garcia, Kristen Gil, Stephen Hemsley, Michele Hooper, F. William McNabb III, Valerie Montgomery Rice, M.D. and John Noseworthy, M.D.

Shareholders also:

  • Approved the advisory resolution on the Company’s executive compensation.
  • Ratified Deloitte & Touche LLP as the Company’s independent registered public accounting firm.
  • Voted against the shareholder proposal requesting a shareholder vote regarding excessive golden parachutes.

At its regular quarterly meeting, the Board authorized payment of a cash dividend of $2.21 per share, to be paid June 24, 2025, to common stock shareholders of record as of the close of business June 16, 2025.

About UnitedHealth Group

UnitedHealth Group is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health benefits, enabling affordable coverage, simplifying the health care experience and delivering access to high-quality care. Visit UnitedHealth Group at www.unitedhealthgroup.com and follow UnitedHealth Group on LinkedIn.

Stock Quote

Last Trade: US$307.70
Daily Change: 3.99 1.31
Daily Volume: 7,594,987
Market Cap: US$279.130B

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

End of content

No more pages to load

Next page